Bicara Therapeutics Inc.
BCAXNasdaqCIK 2023658HealthcareFiscal year ends Dec 31
Reports and events: 37 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2520:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-058937 |
| 2026-08-1120:46 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055765 |
| 2026-08-1111:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055500 |
| 2026-07-2812:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-049937 |
| 2026-06-1020:05 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-042176 |
| 2026-05-2121:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-037377 |
| 2026-05-1120:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-033429 |
| 2026-05-1111:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033135 |
| 2026-04-2711:32 ET | DEF 14A | Proxy statementPeriod 2026-04-21 | 0001628280-26-027320 |
| 2026-03-3021:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-022010 |
| 2026-03-3011:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-021868 |
| 2026-03-0221:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000066 |
| 2026-02-2621:06 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076560 |
| 2026-02-1921:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-009808 |
| 2026-01-1213:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-001766 |
| 2025-12-0812:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002023658-25-000112 |
| 2025-11-1021:27 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0002023658-25-000109 |
| 2025-11-1012:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000107 |
| 2025-08-1220:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0002023658-25-000098 |
| 2025-08-1211:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000094 |
| 2025-06-1220:33 ET | 8-K | 5.07 Shareholder vote results | 0002023658-25-000082 |
| 2025-06-0620:47 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0002023658-25-000063 |
| 2025-05-1320:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0002023658-25-000039 |
| 2025-05-1311:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000034 |
| 2025-04-2520:02 ET | DEF 14A | Proxy statementPeriod 2025-06-09 | 0002023658-25-000027 |
| 2025-03-2720:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0002023658-25-000012 |
| 2025-03-2711:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000006 |
| 2025-01-1313:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005002 |
| 2024-11-1221:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0002023658-24-000002 |
| 2024-11-1212:44 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255166 |
| 2024-09-2320:17 ET | SC 13D | Ownership report, active investor | 0001104659-24-102048 |
| 2024-09-1821:10 ET | SC 13D | Ownership report, active investor | 0001999371-24-012103 |
| 2024-09-1620:18 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-219617 |
| 2024-09-1120:23 ET | S-1/A | Registration statement, amended | 0001193125-24-217265 |
| 2024-09-0610:31 ET | S-1/A | Registration statement, amended | 0001193125-24-214674 |
| 2024-09-0311:26 ET | S-1/A | Registration statement, amended | 0001193125-24-211537 |
| 2024-08-2220:38 ET | S-1 | Registration statement | 0001193125-24-205393 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.